Association of (Pro)renin receptor mRNA expression with angiotensin-converting enzyme mRNA expression in human artery

American Journal of Nephrology

Volumn 30, Issue 4, 2009, Pages 361-370

  Takemitsu, Tomoko ^a   Ichihara, Atsuhiro ^a   Kaneshiro, Yuki ^a   Sakoda, Mariyo ^a   Kurauchi Mito, Asako ^a   Narita, Tatsuya ^a   Kinouchi, Kenichiro ^a   Yamashita, Norimasa ^b   Itoh, Hiroshi ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Yoyogi Yamashita Clinic   (Japan)

Author keywords

Angiotensin converting enzyme; Angiotensinogen; Diabetes; Neprilysin; Prorenin

Indexed keywords

ALDOSTERONE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MESSENGER RNA; PRORENIN RECEPTOR; RENIN; TRIACYLGLYCEROL;

AGED; ALDOSTERONE BLOOD LEVEL; ARTERIAL STIFFNESS; ARTICLE; BLOOD LEVEL; BRACHIAL ARTERY; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY DISEASE; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; TISSUE LEVEL;

AGED; ALDOSTERONE; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ARTERIES; ARTERIOVENOUS SHUNT, SURGICAL; DIABETIC NEPHROPATHIES; FEMALE; GENE EXPRESSION REGULATION; HUMANS; HYPERTENSION, RENAL; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PEPTIDYL-DIPEPTIDASE A; RECEPTORS, CELL SURFACE; REGRESSION ANALYSIS; RENIN; RNA, MESSENGER;

EID: 67651230076     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000232199     Document Type: Article

References (39)

1. Nguyen G, Delarue F, Burckle C, Bouzhir L, Giller T, Sraer JD: Pivotal role of the renin/prorenin receptor in angiotensin II production and cellular responses to renin. J Clin Invest 2002; 109: 1417-1427. (Pubitemid 34596167)
2. Ichihara A, Hayashi M, Kaneshiro Y, et al: Inhibition of diabetic nephropathy by a decoy peptide corresponding to the 'handle' region for non-proteolytic activation of prorenin. J Clin Invest 2004; 114: 1128-1135.
3. Miller AG, Heine R, Tan G, Tikellis C, Nguyen G, Wilkinson-Berka JL: Prorenin receptor inhibition attenuates retinal angiogenesis and inflammation in the ischemic and diabetic retina (abstract). ARVO 2008; 213.
4. Ichihara A, Kaneshiro Y, Takemitsu T, et al: Contribution of non-proteolytically activated prorenin in glomeruli to hypertensive renal damage. J Am Soc Nephrol 2006; 17: 2495-2503. (Pubitemid 44300965)
5. Ichihara A, Kaneshiro Y, Takemitsu T, et al: Non-proteolytic activation of prorenin contributes to development of cardiac fibrosis in genetic hypertension. Hypertension 2006; 47: 894-900. (Pubitemid 44297561)
6. Susic D, Zhou X, Frohlich ED, Lippton H, Knight M: Cardiovascular effects of prorenin blockade in genetically hypertensive rats on normal and high salt diet. Am J Physiol 2008; 295:H1117-H1121.
7. Muller DN, Klanke B, Feldt S, Cordasic N, Hartner A, Schmieder RE, et al: (Pro)renin receptor peptide inhibitor 'handle-region' peptide does not affect hypertensive nephrosclerosis in Goldblatt rats. Hypertension 2008; 51: 676-681.
8. Feldt S, Maschke U, Dechend R, Luft FC, Muller DN: The putative (pro)renin receptor blocker HRP fails to prevent (pro)renin signaling. J Am Soc Nephrol 2008; 19: 743-748.
9. Amsterdam A, Nissen RM, Sun Z, Swindell EC, Farrington S, Hopkins N: Identification of 315 genes essential for early zebrafish development. Proc Natl Acad Sci USA 2004; 101: 12792-12797. (Pubitemid 39167537)
10. Kaneshiro Y, Ichihara A, Sakoda M, et al: Slowly progressive, angiotensin II-independent glomerulosclerosis in human-renin/prorenin-receptor-transgenic rats. J Am Soc Nephrol 2007; 18: 1789-1795. (Pubitemid 46870315)
11. Burckle CA, Jan Danser AH, Muller DN, et al: Elevated blood pressure and heart rate in human renin receptor transgenic rats. Hypertension 2006; 47: 552-556.
12. Ramser J, Abidi FE, Burckle CA, et al: A unique exonic splice enhancer mutation in a family with X-linked mental retardation and epilepsy points to a novel role of the renin receptor. Hum Mol Genet 2005; 14: 1019-1027. (Pubitemid 40575877)
13. Ichihara A, Yamashita N, Takemitsu T, et al: Cardio-Ankle Vascular Index and ankle pulse wave velocity as a marker of arterial fibrosis in kidney failure treated by hemodialysis. Am J Kidney Dis 2008; 52: 947-955.
14. Ichihara A, Suzuki H, Saruta T: Effects of magnesium on the renin-angiotensin-aldosterone system in human subjects. J Lab Clin Med 1993; 122: 432-440. (Pubitemid 23346779)
15. Nishiyama A, Seth DM, Navar LG: Renal interstitial fluid angiotensin I and angiotensin II concentrations during local angiotensin-converting enzyme inhibition. J Am Soc Nephrol 2002; 13: 2207-2212. (Pubitemid 34925230)
16. Suzuki F, Hayakawa M, Nakagawa T, et al: Human prorenin has 'gate and handle' regions for its non-proteolytic activation. J Biol Chem 2003; 278: 22217-22222.
17. Kawazu S, Minagawa S, Yazawa M, et al: Sex difference and possible relationship to microvascular complications of serum prorenin levels in type 2 diabetic patients, measured by a novel antibody-activating direct enzyme kinetic assay. J Diabetes Complications 2004; 18: 275-281. (Pubitemid 39165434)
18. Satoh M, Nakamura M, Saitoh H, et al: Tumor necrosis factor-1-converting enzyme and tumor necrosis factor-α in human dilated cardiomyopathy. Circulation 1999; 99: 3260-3265. (Pubitemid 29293436)
19. Wake DJ, Rask E, Livingstone DEW, Soderberg S, Olsson T, Walker BR: Local and systemic impact of transcriptional upregulation of 11β-hydroxysteroid dehydrogenase type 1 in adipose tissue in human obesity. J Clin Endocrinol Metab 2003; 88: 3983-3988. (Pubitemid 37034555)
20. Yamani MH, Cook DJ, Tuzcu EM, et al: Systemic upregulation of angiotensin II type 1 receptor in cardiac donors with spontaneous intracerebral hemorrhage. Am J Transplant 2004; 4: 1097-1102.
21. Sakoda M, Ichihara A, Kaneshiro Y, et al: (Pro)renin receptor-mediated activation of mitogen-activated protein kinases in human vascular smooth muscle cells. Hypertens Res 2007; 30: 1139-1146.
22. Paizis G, Tikellis C, Cooper ME, et al: Chronic liver injury in rats and humans upregulates the novel enzyme angiotensin converting enzyme 2. Gut 2005; 54: 1790-1796. (Pubitemid 41697680)
23. Harmer D, Gilbert M, Borman R, Clark KL: Quantitative mRNA expression profiling of ACE-2, a novel homologue of angiotensin converting enzyme. FEBS Lett 2002; 532: 107-110. (Pubitemid 35375876)
24. Herradon G, Ezquerra L, Nguyen T, et al: Pleiotrophin is an important regulator of the renin-angiotensin system in mouse aorta. Biochem Biophys Res Commun 2004; 324: 1041-1047. (Pubitemid 39361613)
25. Hodroj W, Legedz L, Foundi N, et al: Increased insulin-stimulated expression of arterial angiotensinogen and angiotensin type 1 receptor in patients with type 2 diabetes mellitus and atheroma. Arterioscler Thromb Vasc Biol 2007; 27: 525-531. (Pubitemid 46263396)
26. Luetscher JA, Kraemer FB, Wilson DM, Schwartz HC, Bryer-Ash M: Increased plasma inactive renin in diabetes mellitus: a marker of microvascular complications. N Engl J Med 1985; 312: 1412-1417.
27. Derkx F, Schalekamp M: Human prorenin: pathophysiology and clinical implications. Clin Exp Hypertens 1988;A10: 1213-1225. (Pubitemid 19051360)
28. Wilson DM, Luetscher JA: Plasma prorenin activity and complications in children with insulin-dependent diabetes mellitus. N Engl J Med 1990; 323: 1101-1106. (Pubitemid 20370731)
29. Schefe J, Menk M, Reinemund J, et al: A novel signal transduction cascade involving direct physical interaction of the renin/prorenin receptor with the transcription factor promyelocytic zinc finger protein. Circ Res 2006; 99: 1355-1366. (Pubitemid 44949671)
30. Schefe JH, Neumann C, Goebel M, et al: Prorenin engages the (pro)renin receptor like renin and both ligand activities are unopposed by aliskiren. J Hypertens 2008; 26: 1787-1795.
31. Peters B, Grisk O, Becher B, et al: Dose-dependent titration of prorenin and blood pressure in Cyp1a1ren-2 transgenic rats: absence of prorenin-induced glomerulosclerosis. J Hypertens 2008; 26: 102-109. (Pubitemid 350301935)
32. Siragy HM, Huang J: Renal (pro)renin receptor upregulation in diabetic rats through enhanced angiotensin AT1 receptor and NADPH oxidase activity. Exp Physiol 2008; 93: 709-714.
33. Krebs C, Hamming I, Sadaghiani S, et al: Antihypertensive therapy upregulates renin and (pro)renin receptor in the clipped kidney of Goldblatt hypertensive rats. Kidney Int 2007; 72: 725-730. (Pubitemid 47373792)
34. Senbonmatsu T, Saito T, Landon EJ, et al: A novel angiotensin II type 2 receptor signaling pathway: possible role in cardiac hypertrophy. EMBO J 2003; 22: 6471-6482. (Pubitemid 38009595)
35. Zou Y, Akazawa H, Qin Y, et al: Mechanical stress activates angiotensin II type 1 receptor without the involvement of angiotensin II. Nat Cell Biol 2004; 6: 499-506. (Pubitemid 38786592)
36. Miura S, Kiya Y, Kanazawa T, et al: Differential bonding interactions of inverse agonists of angiotensin II type 1 receptor in stabilizing the inactive state. Mol Endocrinol 2008; 22: 139-146.
37. Velez JC, Bland AM, Arthur JM, Raymond JR, Janech MG: Characterization of renin-angiotensin system enzyme activities in cultured mouse podocytes. Am J Physiol Renal Physiol 2007; 293:F398-F407.
38. Santos RA, Ferreira AJ, Simões E Silva AC: Recent advances in the angiotensin-converting enzyme 2-angiotensin(1-7)-Mas axis. Exp Physiol 2008; 93: 519-527.
39. Simões E Silva AC, Diniz JSS, Pereira RM, Pinheiro SVB, Santos RAS: Circulating renin angiotensin system in childhood chronic renal failure: marked increase of angiotensin-(1-7) in end-stage renal disease. Pediatr Res 2006; 60: 734-739.